270 related articles for article (PubMed ID: 7693853)
1. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.
Tilg H; Vannier E; Vachino G; Dinarello CA; Mier JW
J Exp Med; 1993 Nov; 178(5):1629-36. PubMed ID: 7693853
[TBL] [Abstract][Full Text] [Related]
2. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients.
Gu Y; Ding F; Qin H; Zhao H; Lin S
Chin Med J (Engl); 2000 Apr; 113(4):315-9. PubMed ID: 11775226
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 receptor antagonist: an index of dialysis-induced interleukin-1 production.
Pereira BJ; King AJ; Falagas ME; Dinarello CA
Nephron; 1994; 67(3):358-61. PubMed ID: 7936030
[TBL] [Abstract][Full Text] [Related]
4. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages.
Pue CA; Mortensen RF; Marsh CB; Pope HA; Wewers MD
J Immunol; 1996 Feb; 156(4):1594-600. PubMed ID: 8568265
[TBL] [Abstract][Full Text] [Related]
5. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.
Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM
Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615
[TBL] [Abstract][Full Text] [Related]
6. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.
Vannier E; Miller LC; Dinarello CA
Proc Natl Acad Sci U S A; 1992 May; 89(9):4076-80. PubMed ID: 1533284
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.
Drenth JP; Göertz J; Daha MR; van der Meer JW
Immunology; 1996 Jul; 88(3):355-62. PubMed ID: 8774350
[TBL] [Abstract][Full Text] [Related]
9. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells.
Gabay C; Genin B; Mentha G; Iynedjian PB; Roux-Lombard P; Guerne PA
Clin Exp Immunol; 1995 May; 100(2):306-13. PubMed ID: 7743670
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients.
Pereira BJ; Sundaram S; Snodgrass B; Hogan P; King AJ
J Am Soc Nephrol; 1996 Mar; 7(3):479-87. PubMed ID: 8704115
[TBL] [Abstract][Full Text] [Related]
11. Effects of nonsteroidal anti-inflammatory drugs on interleukin-1 receptor antagonist production in cultured human peripheral blood mononuclear cells.
Kusuhara H; Matsuyuki H; Okumoto T
Prostaglandins; 1997 Nov; 54(5):795-804. PubMed ID: 9491209
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patients.
Balakrishnan VS; Jaber BL; Natov SN; Cendoroglo M; King AJ; Schmid CH; Pereira BJ
Kidney Int; 1998 Dec; 54(6):2106-12. PubMed ID: 9853276
[TBL] [Abstract][Full Text] [Related]
13. Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio.
Luhm J; Langenkamp U; Hensel J; Frohn C; Brand JM; Hennig H; Rink L; Koritke P; Wittkopf N; Williams DL; Mueller A
BMC Immunol; 2006 Mar; 7():5. PubMed ID: 16553947
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell.
Andersson J; Björk L; Dinarello CA; Towbin H; Andersson U
Eur J Immunol; 1992 Oct; 22(10):2617-23. PubMed ID: 1396967
[TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes.
Granowitz EV; Vannier E; Poutsiaka DD; Dinarello CA
Blood; 1992 May; 79(9):2364-9. PubMed ID: 1533323
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
17. Monocyte cytokine production in an elderly population: effect of age and inflammation.
Roubenoff R; Harris TB; Abad LW; Wilson PW; Dallal GE; Dinarello CA
J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M20-6. PubMed ID: 9467429
[TBL] [Abstract][Full Text] [Related]
18. The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: a comparison to interleukin 1 beta (IL-1 beta) and interleukin 1 receptor antagonist (IL-1ra).
Brown EA; Dare HA; Marsh CB; Wewers MD
Cytokine; 1996 Nov; 8(11):828-36. PubMed ID: 9047079
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of benzydamine on pro- versus anti-inflammatory cytokine production: lack of inhibition of interleukin-10 and interleukin-1 receptor antagonist.
Sironi M; Massimiliano L; Transidico P; Pinza M; Sozzani S; Mantovani A; Vecchi A
Int J Clin Lab Res; 2000; 30(1):17-9. PubMed ID: 10984127
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.
Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P
Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
